2Anstee QM,Day CP.S-adenosylmethionine(SAMe)therapy in liver disease:a review of current evidence and clinical utility[J].J Hepatol,2012,57(5):1 097.
3Lieber CS,Weiss DG,Groszmann R,et al.I Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease:effects on drinking behavior by nurse/physician teams[J].Alcohol Clin Exp Res,2003,27(11):1 757.
4Farrell GC,Chitturi S,Lau GK,et al.Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region:executive summary[J].J Gastroenterol Hepatol,2007,22(6):775.
5Devarbhavi H.An update on drug-induced liver injury[J].J Clin Exp Hepatol,2012,2(3):247.